MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease

Annals of Neurology - United States
doi 10.1002/ana.25450
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Wiley

Related search

Depletion of AADC Activity in Caudate Nucleus and Putamen of Parkinson’s Disease Patients; Implications for Ongoing AAV2-AADC Gene Therapy Trial

PLoS ONE
Multidisciplinary
2017English

Comparison of MRI-guided and Ventriculography-Based Stereotactic Surgery for Parkinson's Disease

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1997English

A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

MRI-guided STN DBS in Parkinson's Disease Without Microelectrode Recording: Efficacy and Safety

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2010English

Phase 1 Study of Stereotactic Body Radiation Therapy for Liver Tumors Utilizing an MRI-Guided Tri-Co Teletherapy System

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Reduced Dorsolateral Putaminal Connectivity in Resting State FMRI in Parkinson's Disease

Journal of the Neurological Sciences
Neurology
2015English

200. Advancing a State of the Art Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Gene Therapy for Pain: Results of a Phase I Clinical Trial

Annals of Neurology
Neurology
2011English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy